• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Akero Therapeutics Inc (NQ: AKRO )

    19.92 -0.81 (-3.91%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 457,666
    Open 20.79
    Bid (Size) 18.80 (1)
    Ask (Size) 20.75 (1)
    Prev. Close 20.73
    Today's Range 19.76 - 20.82
    52wk Range 11.25 - 58.38
    Shares Outstanding 50,086,978
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    WHY: NEW YORK, NY - (NewMediaWire) - May 19, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ: AKRO) between September... 
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal

    Performance

    YTD
    -15.16%
    -15.16%
    1 Month
    -4.05%
    -4.05%
    3 Month
    -7.86%
    -7.86%
    6 Month
    +19.50%
    +19.50%
    1 Year
    -56.37%
    -56.37%

    More News

    Read More
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lincoln, Compass Minerals, Exscientia, and Akero and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, NATIONAL TRIAL LAWYERS, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, NATIONAL TRIAL LAWYERS, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    Abraham, Fruchter & Twersky LLP Notifies Shareholders of a Class Action Lawsuit on Behalf of Investors who Acquired Shares of Akero Therapeutics, Inc. (NYSE: AKRO)
    From Abraham, Fruchter & Twersky, LLP
    Via GlobeNewswire
    Robbins LLP Reminds Investors of AKRO of the Pending Lead Plaintiff Deadline in the Akero Therapeutics, Inc. Class Action
    From Robbins LLP
    Via GlobeNewswire
    ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeutics
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    ROSEN, A LEADING NATIONAL FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, A LEADING NATIONAL FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors with losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors with losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    Kirby McInerney LLP Reminds Akero Therapeutics, Inc. (AKRO) Investors of Class Action Filing and Encourages Investors to Contact the Firm
    From Kirby McInerney LLP
    Via Business Wire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Exscientia, Akero, Equinix, and Harbor Diversified and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    AKRO Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Akero Therapeutics, Inc.
    From Robbins LLP
    Via Business Wire
    ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKRO
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    AKRO Stock Earnings: Akero Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
    From Glancy Prongay & Murray LLP
    Via Business Wire
    Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    From Akero Therapeutics Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.